AstraZeneca pays $1.3bn for gout-buster drug
The burst of M&A activity in the pharmaceuticals industry continued yesterday when AstraZeneca announced a $1.26bn (£783m) deal to buy the US company Ardea Biosciences, which is working on a new medicine to battle gout.
Astra, Britain's second-biggest drugmaker, is facing a patent cliff, as lucrative blockbusters including its antipsychotic Seroquel begin to face generic competition, while several medicines in its pipeline have failed at late-stage trials.
Shareholders will hope the deal to buy California's Ardea for $32 a share – 54 per cent above its closing share price on Friday – will bolster Astra's prospects. Ardea's Lesinurad is in late-stage development as a potential treatment for chronic gout, which is expected to affect almost 17 million people by 2019.
David Brennan, AstraZeneca's chief executive, said: "The Ardea team has done a great job developing Lesinurad along with a promising next-generation gout programme. These compounds have real potential to benefit patients."
- 1 Liam Gallagher brands Kanye West 'utter s**t' during BRIT Awards performance
- 2 Isis burns thousands of books and rare manuscripts from Mosul's libraries
- 3 People who sleep more than eight hours are more likely to have a stroke, research shows
- 4 Kanye West climbs on table at Nando's to crowd chants of 'Yeezus' before Brit Awards 2015 performance of 'All Day'
- 5 New theory could prove how life began and disprove God
Oscars 2015: Birdman beats Boyhood as Eddie Redmayne and Patricia Arquette win big - as it happened
New theory could prove how life began and disprove God
Half of Ukip voters say they are prejudiced against people of other races
'Cash for access' scandal: Sir Malcolm Rifkind says 'unrealistic' for MPs to live on £67,000 salary
Aqsa Mahmood branded a 'disgrace' by her parents after claims she recruited three UK girls flying to Middle East
This is what it's like to be dead, according to a guy who died for a bit
iJobs Money & Business
£17000 - £25000 per annum: Recruitment Genius: An opportunity to join this new...
£18000 - £21000 per annum + OTE £45,000: SThree: SThree Group have been well e...
£20000 - £25000 per annum + OTE £45,000: SThree: SThree Group have been well e...
£36000 - £44000 per annum: Recruitment Genius: Encouraging more businesses to ...